| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 02/09/2006 | US20060029580 Method for treating a condition with neural progenitor cells derived from whole bone marrow |
| 02/09/2006 | DE69717294C5 Chinazolin derivate und diese enthaltende pharmazeutische zusammenstellungen Quinazoline derivatives and those containing pharmaceutical assortments |
| 02/09/2006 | CA2592044A1 Pharmaceutical composition comprising fgf18 and il-1 antagonist and method of use |
| 02/09/2006 | CA2578261A1 Pyrazole derivative |
| 02/09/2006 | CA2576028A1 Heterocyclic compounds useful as dpp- iv inhibitors |
| 02/09/2006 | CA2574626A1 Antiplatelet agent and process for producing the same |
| 02/09/2006 | CA2573573A1 Fused ring heterocycle kinase modulators |
| 02/09/2006 | CA2573000A1 Composition containing statins and omega-3 fatty acids |
| 02/08/2006 | EP1623984A1 Polymorphic form I of 5-[4-[[3-methyl-4-oxo-3,4-dihydroquinazolin-2yl]methoxy]benzyl]thiazolidine-2,4-dione potassium salt |
| 02/08/2006 | EP1623983A1 Heterocyclic compounds useful as DPP-IV inhibitors |
| 02/08/2006 | EP1623974A1 2"-hydroxynicotianamine, process for producing the same and angiotensin converting enzyme inhibitor, hypotensive drug and health food |
| 02/08/2006 | EP1623728A1 Nitric oxide-releasing metallic medical devices |
| 02/08/2006 | EP1623721A1 Effector cell function inhibitor |
| 02/08/2006 | EP1623712A2 Selective estrogen receptor modulator in combination with dehydroepiandrosterone (DHEA) or analogues |
| 02/08/2006 | EP1623711A1 External patch containing estrogen and/or progestogen |
| 02/08/2006 | EP1623710A1 Receptor antagonist |
| 02/08/2006 | EP1622936A1 Method for the production of an n-terminally modified chemotactic factor |
| 02/08/2006 | EP1622897A1 Inhibitors of phosphatidylinositol 3-kinase |
| 02/08/2006 | EP1622885A2 Dihydrothiazine prodrugs of thiazolium agents |
| 02/08/2006 | EP1622685A1 9-azabicyclo[3.3.1]non-6-ene derivatives with a heteroatom at the 3-position as renin inhibitors |
| 02/08/2006 | EP1622609A2 Methods for treating degenerative diseases/injuries |
| 02/08/2006 | EP1622607A1 Angiotensin ii receptor blockers for preventing the development or progression of microvascular disease due to diabetes |
| 02/08/2006 | EP1622564A2 Diazabicyclononene derivatives |
| 02/08/2006 | EP1622455A2 Gemini vitamin d3 compounds and methods of use thereof |
| 02/08/2006 | EP1478393A4 Anti-pathogen treatements |
| 02/08/2006 | EP1406865B1 Succinic acid derivatives |
| 02/08/2006 | EP1358162B1 Dihydroindole and tetrahydroquinoline derivatives |
| 02/08/2006 | EP1318978B1 N-acylsulfonamide apoptosis promoters |
| 02/08/2006 | EP1297006B1 Regulation of human prostasin-like serine protease |
| 02/08/2006 | EP1265871B1 Pyridazinyl phenyl hydrazones useful against congestive heart failure |
| 02/08/2006 | EP1235776B1 Triphenylalkene derivatives and their use as selective estrogen receptor modulators |
| 02/08/2006 | EP1187815B1 4-phenyl-pyrimidine derivatives |
| 02/08/2006 | EP1112362B1 GENE MODIFICATION IN THE GENE FOR THE DIE G$g(b)3-SUB-UNIT OF HUMAN G-PROTEIN |
| 02/08/2006 | EP0969855B1 Novel low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 02/08/2006 | CN1732182A Peptides and medicinal compositions containing the same |
| 02/08/2006 | CN1732161A 1,3-diamino-2-hydroxypropane pro-drug derivatives |
| 02/08/2006 | CN1732159A 2-oxopyrimidine derivatives and their use as human leukocyte elastase inhibitors |
| 02/08/2006 | CN1731999A Benzothiazole derivatives |
| 02/08/2006 | CN1730665A PI3K enzyme inhibitor quick-speed screening method |
| 02/08/2006 | CN1730488A Peptides for promoting platelet growth, accumulation and suppressing hypertension and its uses |
| 02/08/2006 | CN1730098A Composition containing active prourokinase, freeze-drying process and freeze-dried preparation thereof |
| 02/08/2006 | CN1730094A Ginger and dried orange peel extracts mixture for treating cardiovascular disease |
| 02/08/2006 | CN1730089A Chinese traditional medicine with hemorrhoid resolving, poison expelling and stagnation expelling functions |
| 02/08/2006 | CN1730088A Spray for curing cardiopathy |
| 02/08/2006 | CN1730069A Anti- paralysis capsule |
| 02/08/2006 | CN1730066A Chinese medicinal formulation for treating asthma and cough |
| 02/08/2006 | CN1730048A Chinese medicinal composition for treating piles and anal fissure and process for preparing the same |
| 02/08/2006 | CN1730045A Medicine for treating piles and its preparing process |
| 02/08/2006 | CN1730044A Process for preparing quick-acting spray for cardiac pain |
| 02/08/2006 | CN1730039A Process for preparing cough-stopping dripping pills |
| 02/08/2006 | CN1730037A Process for preparing thrombus eliminating dripping pills |
| 02/08/2006 | CN1730031A Hypertension treating medicine |
| 02/08/2006 | CN1730029A Method for preparing red sage formulation or buccal tablet for treating coronary disease |
| 02/08/2006 | CN1730026A Dripping pills of corydalis tuber and its preparation process |
| 02/08/2006 | CN1730021A Medicine composition for treating cardiovascular and cerebrovascular diseases and preparing process thereof |
| 02/08/2006 | CN1730018A Pharmaceutical composition for treating cardiovascular and cerebrovascular diseases and preparing process and application thereof |
| 02/08/2006 | CN1730016A Health caring product prescription for treating cardiovascular and cerebrovascular disease and its preparation process |
| 02/08/2006 | CN1730013A Medicine composition for treating cardiovascular and cerebrovascular disease and its preparation method |
| 02/08/2006 | CN1730012A Chinese medicinal formulation containing scutellarin and its preparing process |
| 02/08/2006 | CN1730009A Novel drug administering route of ginseng stem and leave general saponin and its preparation process and new indications |
| 02/08/2006 | CN1730008A Pharmaceutical composition for preventing and treating cardiac and cerebral vascular disease |
| 02/08/2006 | CN1730007A Notoginseng dispersible tablet and its preparing process |
| 02/08/2006 | CN1730005A Method for preparing dripping pills of ganoderma lucidum |
| 02/08/2006 | CN1729988A Composite medicine of creatine phosphate sodium and magnesium salt |
| 02/08/2006 | CN1729985A Fasudil hydrochloride injection and its preparation process |
| 02/08/2006 | CN1729984A Freeze dry formulation of fasudil hydrochloride and its preparation process |
| 02/08/2006 | CN1729982A Prescription of compound bendazol and hydrochlorothiazide capsule and its preparation process |
| 02/08/2006 | CN1729969A Flavone hippophaes drop pills and method for preparing the same |
| 02/08/2006 | CN1729967A Propylgallate injection with favorable solubility and its preparation process |
| 02/08/2006 | CN1729966A Injecting composition containing Sodium Danshensu |
| 02/08/2006 | CN1240836C Transforming growth factor alpha HI |
| 02/08/2006 | CN1240716C Pituitary adenylate cyclase activated polypeptide derivatives and process for preparing the same |
| 02/08/2006 | CN1240711C Novel peptide having angiotensin convertase inhibitory effect |
| 02/08/2006 | CN1240688C Quinazoline compounds |
| 02/08/2006 | CN1240681C Nitrile derivatives as cathepsin K inhibitors |
| 02/08/2006 | CN1240427C Piles treating pill |
| 02/08/2006 | CN1240424C Chinese medicine for treating vascular dementia and its preparation process |
| 02/08/2006 | CN1240423C Coronary heart disease treating Chinese medicine and its preparation |
| 02/08/2006 | CN1240416C Medicine for treating hypertension and its preparation method |
| 02/08/2006 | CN1240412C Chinese medicine compound preparation for treating piles and preparing process thereof |
| 02/08/2006 | CN1240394C Medication for anti ischemia and reperfusion damage |
| 02/08/2006 | CN1240393C Application of astragalus root polysaccharide in preparation of antilipemic agent and health products |
| 02/08/2006 | CN1240391C Daidzein drip pill and its preparation method |
| 02/08/2006 | CN1240388C Selective estrogen receptor modulator in combination with dehydroepiandrosterone or its derivative |
| 02/08/2006 | CN1240387C Folic acid-containing pharmaceutical compositions, and related methods and delivery systems |
| 02/08/2006 | CN1240385C Method for preparing nimodipine carrying float sustained release mini capsule |
| 02/08/2006 | CN1240377C Stable pharmaceutical composition of pravastatin |
| 02/08/2006 | CN1240323C Oxidation-inhibited biological nutritive healthy liquid and preparing method thereof |
| 02/07/2006 | US6995285 ABCA-1 elevating compounds |
| 02/07/2006 | US6995238 Cyclopeptide derivatives |
| 02/07/2006 | US6995184 Such as (7-chloro-2-methyl-1-(3-(methylsulphanyl)propyl)-1H-indol-3-yl)(2,3-dichloro-phenyl)methanone; cannabinoid receptors (cb2); G proteins coupled receptors |
| 02/07/2006 | US6995182 1-sulfonyl pyrrolidine derivatives |
| 02/07/2006 | US6995163 having an excellent corticotrophin-releasing-factor receptor antagonistic activity; for treating or preventing depression, nerve system disorders, schizophrenia, peptic ulcer, irritable bowel syndrome |
| 02/07/2006 | US6995162 Substituted alkylamine derivatives and methods of use |
| 02/07/2006 | US6995161 Central nervous system disorders |
| 02/07/2006 | US6995159 4-piperazin-1-yl-2-(pyridin-2-ylmethoxy)-pyrimidine, 2-(6-methyl-pyridin-2-ylmethoxy)-4-piperazin-1-yl-pyrimidine, and 2-(6-chloro-pyridin-2-ylmethoxy)-4-piperazin-1-yl-pyrimidine; for treatment of seizure and eating disorders; reduced side effects |
| 02/07/2006 | US6995151 Isophthalic acid derivatives as matrix metalloproteinase inhibitors |
| 02/07/2006 | US6995150 Pharmaceutical compositions and uses for androst-5-ene-3β, 17β-diol |
| 02/07/2006 | US6995144 for example, 6-[2-[4-(2-fluorophenoxymethyl)piperidino]ethyl]-1H-pyrazin-2-one; therapeutic or prophylactic agent for diabetic neuralgia, HIV neuralgia, postherpetic neuralgia, nerve system disorders |
| 02/07/2006 | US6994993 Nucleotide sequences coding membrane protein for use inthe treatment of epilepsey, arrhythmia, and pain in humans |